April 2008 - Page 63 of 74

SundayApr 06, 2008 7:49 am

StockGuru Announces Coverage of: NextGen Bioscience (NXGB)

NextGen Bioscience, Inc. (OTC: NXGB) is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. All product candidates target indications with significant unmet need and substantial market potential. Subsequent value-addition at low cost brings benefits to both patients and stakeholders. These programs will then be transferred to larger organizations, either other biotech companies and/or Big Pharma, who have the infrastructure to bring the products to market. All acquisition candidates are underpinned by patent applications or granted patents which confer protection in the…

SundayApr 06, 2008 7:48 am

StockGuru Blog: More from New Profile NextGen Bioscience (NXGB)

NextGen Bioscience, Inc. is a drug development biotechnology company focused on the identification, evaluation and acquisition of drug candidates for treatment and prevention of oncological and infectious diseases in human beings. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. NextGen’s business model is to acquire promising new patented technologies in the fields of cancer and infectious disease, to add significant value to these by advancing them through toxicological assessment or Phase I clinical trials and then outlicensing the technology to a larger partner who…

SundayApr 06, 2008 7:47 am

StockGuru Blog: NextGen Bioscience (NXGB) – Biotechnology Company with World Class Management

NextGen Bioscience, Inc. is a drug target acquisition and development company focused on identifying, evaluating and acquiring pioneering innovative cancer research patents, and adding substantial value to those products to demonstrate ‘proof of principle’. The Company is focused on the discovery, development and commercialization of novel therapeutics to fight cancer, in prostate and breast cancer. “NextGen” leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical companies. All acquisition candidates are underpinned by patent applications or granted patents which confer protection in the major jurisdictions worldwide. NextGen’s business model…

SaturdayApr 05, 2008 5:48 am

Stocks in the Spotlight Featured Company: Dynamic Response Group, Inc. (DRGP.OB)

Dynamic Response Group, Inc. (DRG) is an established media brander, content producer, and licensor of products. As a marketing company, they focus on offering innovative marketing solutions that will help sell various products. They deal with products that help consumers solve personal problems or situations, from thinning hair to pest control. As a content producer, they focus on enthusiasms, from living a healthy lifestyle to being an avid sports fan. The company utilizes their in-house resources to target customers across various channels, including direct response television (DRTV), the Internet, catalogs, radio, direct mail, and - more specifically - retail markets.…

FridayApr 04, 2008 7:00 pm

China Voice Holding Corp. (CHVC.OB) Appoints Rafael M. Zambrano as Chief Technology Officer

China Voice Holding Corporation (CHVC.OB), a provider of Voice over Internet Protocol (“VoIP”) telephone services, office automation, wireless broadband, unified messaging, video conferencing, mobility services and other advanced voice and data services in China, recently announced the appointment of Rafael M. Zambrano as the company’s chief technology officer. In this new role, Mr. Zambrano’s will manage the company’s Chinese installations with China Netcom, China’s number two broadband communications and fixed-line telecommunications operator. Mr. Zambrano brings more than 19 years of experience in senior-level international project management, engineering, product development and strategic business development in the telecommunications industry. China Voice Holding…

FridayApr 04, 2008 3:58 pm

Agri-Biz Grows on With Archer Daniels Midland Co. (ADM)

With the economy semi-officially pronounced as in, or on, the verge of a recession, investors are looking for good news. The agricultural business, heavily related to commodities and commodity prices, has seen its difficulties, yet several companies are plowing through these times and doing quite well. Global agricultural conglomerate Archer Daniels Midland (NYSE: ADM) is one. ADM, the agricultural commodities and products company, manufactures, stores, processes, transports and sells a wide variety of agricultural and agriculture-related products. It has three divisions: the Oilseeds Processing division, which concentrates mainly on soy, peanut, cottonseed and other oilseed processing and products; the Corn…

FridayApr 04, 2008 3:38 pm

Global Roaming Distribution, Inc. (GRDB.OB) – The Momentum Builds

A tremendous amount of positives took place in 2007 for Global Roaming Distribution, Inc. (OTCBB:GRDB), a telecommunications holding company specializing in providing extremely low cost roaming solutions for corporations and leisure travelers around the globe. In fact, the end of 2007 found CelTrek (a division of Global Roaming) among a prestigious list of Florida companies who won The Greater Miami Chamber of Commerce's first ever International Business Leadership Awards. In spite of that, GRDB has not been resting on its laurels, and 2008 is shaping up to be even more exciting than 07. In just the first quarter of the…

FridayApr 04, 2008 3:34 pm

Kensey Nash Corp. (KNSY) Receives FDA Clearance for Vessel Wall Detection Technology

Kensey Nash Corp. (KNSY), headquartered in Exton, Pennsylvania, is a medical technology company that provides innovative solutions and technologies for a wide range of medical procedures. The company provides an extensive range of products for multiple medical markets, primarily in the endovascular, sports medicine and spinal markets. Kensey has also commercialized a series of innovative products through its own direct endovascular sales force. Recently, the company received 510K clearance for an important vessel-wall detection technology from the U.S. Food and Drug Administration. The technology was designed to enhance the guidance provided by the Safe-Cross® RF CTO System. The Safe-Cross System…

FridayApr 04, 2008 3:32 pm

NACEL Energy Corporation (NCEN.OB) Offers Alternative Energy from the Air

We are living on the cusp of a new era. As the world rapidly draws nearer to the close of the fossil-fuel age, it becomes increasingly apparent to investors that the light at the end of the tunnel is in fact powered by renewable energy. One of the most desirable alternative power sources, wind energy, is quickly becoming a focus for those seeking a truly "green" solution to the global problem of resource depletion. The reasons for this are indeed bountiful. Wind energy is clean, it does not produce greenhouse gases and other pollutants like more traditional sources, and it…

FridayApr 04, 2008 3:25 pm

Fund.com, Inc. (FNDM.OB) Takes Advantage of Surging Fund Business

According to The Economist, the global fund business is a $64 trillion business. Morningstar reports that there are approximately 114,000 mutual funds worldwide – and that number continues to grow. The Investment Company Institute reports a 1,196 percent increase in U.S. fund investors since 1980, currently at 55 million. Fund.com (OTCBB: FNDM), recently featured in EQUITIES magazine, is taking advantage of the booming fund community by publishing information about various channels of pooled investment opportunities via the Internet. The company’s online location was designed to connect individual investors with providers of investment and related funds. The company likens its business…

Site Search

Company Search

Month: April 2008